Comas-Calonge
A, Figueiredo R, Gay-Escoda C. Surgical treatment vs. conservative treatment in
intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review. J Clin Exp Dent. 2017;9(2):e302-7.
doi:10.4317/jced.53504
References
|
1. Wilde F, Heufelder M,
Winter K, Hendricks J, Frerich B, Schramm A, et al. The role of surgical
therapy in the management of intravenous bisphosphonates-related
osteonecrosis of the jaw.OralSurg Oral Med Oral Pathol Oral RadiolEndod. 2011;111:153-63. |
|
|
|
|
|
2. Bagan JV, Hens-Aumente
E, Leopoldo-Rodado M, Poveda-Roda R, Bagan L. Bisphosphonate-related
osteonecrosis of the jaws: study of the staging system in a series of
clinical cases. Oral Oncol. 2012;48:753-7. |
|
|
|
|
|
3. Ruggiero SL, Dodson TB,
Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral
and Maxillofacial Surgeons position paper on bisphosphonate-related
osteonecrosis of the jaws -2009 Update. J Oral Maxillofac Surg. 2009;67:2-12. |
|
|
|
|
|
4. Hoefert S, Eufinger H.
Relevance of a prolonged preoperative antibiotic regime in the treatment of
bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2011;69:362-80. |
|
|
|
|
|
5. Wutzl A, Pohl S,
Sulzbacher I, Seemann R, Lauer G, Ewers R, et al. Factors influencing
surgical treatment of bisphosphonate related osteonecrosis of the jaws. Head
Neck. 2012;34:194-200. |
|
|
|
|
|
6. Urrútia G, Confill X.
Prisma declaration: A proposal to improve the publication of systematic
reviews and meta-analysis. Med Clin (Barc). 2010;135:507-11. |
|
|
|
|
|
7. Stanton DC, Balasanian
E. Outcome of surgical management of bisphosphonate-related osteonecrosis of
the jaws: review of 33 surgical cases. J Oral Maxillofac Surg. 2009;67:943-50. |
|
|
|
|
|
8.
Voss PJ, JoshiOshero J, Kovalova-Müller A, Veigel Merino EA, Sauerbier S,
Al-Jamali J, et al. Surgicaltreatment
of bisphosphonate-associated osteonecrosis of the jaw: technical report and
followup of 21 patients. J Craniomaxillofac Surg. 2012;40:719-25. |
|
|
|
|
|
9.
Junquera L, Gallego L, Cuesta P, Pelaz A, de Vicente JC. Clinical experiences with bisphosphonate-associated
osteonecrosis of the jaws: analysis of 21 cases. Am J Otolaryngol. 2009;30:390-5. |
|
|
|
|
|
10. Bedogni A, Saia G,
Bettini G, Tronchet A, Totola A, Bedogni G, et al. Long-term outcomes of
surgical resection of the jaws in cancer patients with bisphosphonate-related
osteonecrosis. Oral Oncol. 2011;47:420-4. |
|
|
|
|
|
11. Mücke T, Koschinski J,
Deppe H, Wagenpfeil S, Pautke C, Mitchell DA, et al. Outcome of treatment and
parameters influencing recurrence in patients with bisphosphonate-related
osteonecrosis of the jaws. J Cancer Res ClinOncol. 2011;137:907-13. |
|
|
|
|
|
12. Martins MA, Martins
MD, Lascala CA, Curi MM, Migliorati CA, Tenis CA, et al. Association of laser
phototherapy with PRP improves healing of bisphosphonate-related
osteonecrosis of the jaws in cancer patients: a preliminary study. Oral
Oncol. 2012;48:79-84. |
|
|
|
|
|
13. Mozzati M, Gallesio G,
Arata V, Pol R, Scoletta M. Platelet-rich therapies in the treatment of
intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32
cases. Oral Oncol. 2012;48:469-74. |
|
|
|
|
|
14. Ferlito S, Puzzo S,
Palermo F, Verzì P. Treatment of bisphosphonate-related osteonecrosis of the
jaws: presentation of a protocol and an observational longitudinal study of
an Italian series of cases. Br J Oral Maxillofac Surg. 2012;50:425-9. |
|
|
|
|
|
15. Freiberger JJ,
Padilla-Burgos R, Chhoeu AH, Kraft KH, Boneta O, Moon RE, et al. Hyperbaric
oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.
J Oral Maxillofac Surg. 2007;65:1321-7. |
|
|
|
|
|
16. Freiberger JJ. Utility
of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of
the jaws. J Oral Maxillofac Surg. 2009;67:96-106. |
|
|
|
|
|
17. Ruggiero SL, Dodson
TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association
of Oral and Maxillofacial Surgeons Position Paper on Medication-Related
Osteonecrosis of the Jaw -2014 Update. J Oral Maxillofac Surg. 2014;72:1938-56. |
|
|
|
|
|
18.
Graziani F, Vescovi P, Campisi G, Favia G, Gabriele M, Gaeta GM, et al. Resective surgical approach shows a high performance
in the management of advanced cases of bisphosphonate-related osteonecrosis
of the jaws: a retrospective survey of 347 cases. J Oral Maxillofac Surg.
2012;70:2501-7. |
|
|
|
|
|
19. Carlson ER, Basile JD.
The role of surgical resection in the management of bisphosphonate-related
osteonecrosis of the jaws. J Oral Maxillofac Surg. 2009;67:85-95. |
|
|
|
|
|
20. Pautke C, Bauer F,
Otto S, Tischer T, Steiner T, Weitz J, et al. Fluorescence-guided bone
resection in bisphosphonate-related osteonecrosis of the jaws: first clinical
results of a prospective pilot study. J Oral Maxillofac Surg. 2011;69:84-91. |
|
|
|
|
|
21. Stockmann P,
Vairaktaris E, Wehrhan F, Seiss M, Schwarz S, Spriewald B, et al. Osteotomy and
primary wound closure in bisphosphonate-associated osteonecrosis of the jaw:
a prospective clinical study with 12 months follow-up. Support Care Cancer.
2010;18:449-60. |
|
|
|
|
|
22.
Vescovi P, Manfredi M, Merigo E, Meleti M, Fornaini C, Rocca JP, et al. Surgical approach with Er:YAG laser on osteonecrosis
of the jaws (ONJ) in patients under bisphosphonate therapy (BPT). Lasers Med
Sci. 2010; 25:101-13. |
|
|
|
|
|
23. Curi MM, Cossolin GS,
Koga DH, Zardetto C, Christianini S, Feher O, et al. Bisphosphonate-related
osteonecrosis of the jaws--an initial case series report of treatment
combining partial bone resection and autologous platelet-rich plasma. J Oral
Maxillofac Surg. 2011;69:2465-72. |
|
|
|
|
|
24. Moretti F, Pelliccioni
GA, Montebugnoli L, Marchetti C. A prospective clinical trial for assessing
the efficacy of a minimally invasive protocol in patients with
bisphosphonate-associated osteonecrosis of the jaws.OralSurg Oral Med Oral
Pathol Oral RadiolEndod. 2011;112:777-82. |
|
|
|
|
|
25.
Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayianni A,
Kyrtsonis MC, et al. Osteonecrosis
of the jaw in oncology patients treated with bisphosphonates: prospective
experience of a dental oncology referral center. Oral Surg Oral Med Oral
Pathol Oral RadiolEndod. 2011;112:195-202. |
|
|
|
|
|
26.
Fortuna G, Ruoppo E, Pollio A, Aria M, Adamo D, Leuci S, et al. Multiple myeloma vs. breast cancer patients with bisphosphonates-related
osteonecrosis of the jaws: a comparative analysis of response to treatment
and predictors of outcome. J Oral Pathol Med. 2012;41:222-8. |
|
|
|
|
|
27. Lerman MA, Xie W,
Treister NS, Richardson PG, Weller EA, Woo SB. Conservative management of
bisphosphonate-related osteonecrosis of the jaws: staging and treatment
outcomes. Oral Oncol. 2013;49:977-83. |
|
|
|
|
|
28. Montebugnoli L,
Felicetti L, Gissi DB, Pizzigallo A, Pelliccioni GA, Marchetti C.
Biphosphonate-associated osteonecrosis can be controlled by nonsurgical
management. Oral Surg Oral Med Oral Pathol Oral RadiolEndod. 2007;104:473-7. |
|
|
|
|
|
29. Rupel K, Ottaviani G,
Gobbo M, Contardo L, Tirelli G, Vescovi P, et al.A systematic review of
therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw
(BRONJ). Oral Oncol. 2014;50:1049-57. |
|